The India Cements Limited has announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The company reported a Profit/(Loss) for the period from continuing operations of ₹38.85 crore for the quarter and ₹65.47 crore for the half-year on a standalone basis. Consolidated figures also showed similar profit trends. The results, approved by the Board of Directors, reflect the company’s financial performance during the period.
India Cements Announces Financial Results
The India Cements Limited has released its unaudited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results at a meeting held on October 17, 2026.
Standalone Financial Performance
On a standalone basis, the company reported a Profit/(Loss) for the period from continuing operations of ₹38.85 crore for the quarter ended September 30, 2026, compared to ₹26.62 crore in the previous year’s corresponding quarter. For the half-year ended September 30, 2026, this figure stood at ₹65.47 crore.
Total Income for the quarter rose to ₹1,145.45 crore from ₹1,022.62 crore in the prior year. The Net Profit Margin for the quarter was 3.39%.
Consolidated Financial Performance
The consolidated financial results showed a Profit/(Loss) for the period from continuing operations of ₹38.82 crore for the quarter ended September 30, 2026. For the half-year ended September 30, 2026, the consolidated profit was ₹65.67 crore.
Total Consolidated Income for the quarter was ₹1,145.70 crore. The Consolidated Net Profit Margin for the quarter was also 3.39%.
Key Financial Highlights
The company’s financial statements include detailed breakdowns of revenue, expenses, and other comprehensive income. Notable items include Total Expenses for the standalone quarter at ₹1,093.14 crore and for the consolidated quarter at ₹1,093.42 crore.
Earnings per equity share (basic and diluted) for the continuing operations on a standalone basis were ₹1.25 for the quarter.
Source: BSE
